About: Safety and Immunogenicity of IMVAMUNE® (MVA-BN®) Smallpox Vaccine in HIV Infected Patients

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Safety and Immunogenicity of IMVAMUNE® (MVA-BN®) Smallpox Vaccine in HIV Infected Patients Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

clinical trial

Attributes	Values
rdf:type	Item
description	clinical trial (en) ensayu clínicu (ast) klinisch onderzoek (nl) клінічне випробування (uk)
rdfs:label	Safety and Immunogenicity of IMVAMUNE® (nl) Safety and Immunogenicity of IMVAMUNE® (MVA-BN®) Smallpox Vaccine in HIV Infected Patients (en)
skos:prefLabel	Safety and Immunogenicity of IMVAMUNE® (nl) Safety and Immunogenicity of IMVAMUNE® (MVA-BN®) Smallpox Vaccine in HIV Infected Patients (en)
name	Safety and Immunogenicity of IMVAMUNE® (nl) Safety and Immunogenicity of IMVAMUNE® (MVA-BN®) Smallpox Vaccine in HIV Infected Patients (en)
title	wds:Q65390948-EA035BE2-E7AF-4176-A3B1-56379BA2DE2F
title	A Multicenter, Open-label, Controlled Phase II Study to Evaluate Safety and Immunogenicity of MVA-BN® (IMVAMUNE) Smallpox Vaccine in 18-55 Year Old Naive and Previously Vaccinated HIV Infected Subjects With CD4 Counts >200 - 750/µl. (en)
end time	wds:Q65390948-2FCB5B71-9130-494E-905E-3DF9B151EF32
end time	2009-03-01 00:00:00Z (xsd:dateTime)
instance of	wds:Q65390948-6765201D-9751-4B74-8A5F-049C8B7E8414
instance of	clinical trial
start time	wds:Q65390948-2548B321-094B-4D50-92B3-59BFF914D692
start time	2006-06-01 00:00:00Z (xsd:dateTime)
country	wds:Q65390948-3A293D70-A781-4836-8BCE-EC6D7DD7A591
country	United States of America
research site	wds:Q65390948-05E49365-3C33-4433-A314-5F06AE2A11C9 wds:Q65390948-2783F237-FDF3-4E43-88E0-63A305C0FC1E wds:Q65390948-28319FC6-D314-4A78-A1DF-770702B1C666 wds:Q65390948-7683AD9E-1465-475C-B325-B7D24FB4F045 wds:Q65390948-87A64B52-EDC6-4484-BAB9-B84FA84A2577 wds:Q65390948-A96826E3-4A7B-424B-A39C-7CB25D6CD44C wds:Q65390948-C97C8D17-9837-43CA-8DBF-0867A78B8441
research site	University of South Carolina University of Nebraska Medical Center Washington University School of Medicine University of Oklahoma University of Pennsylvania Clinical Research of West Florida Providence Clinical Research
minimum age	wds:Q65390948-0461582A-753D-4602-92A6-8FE2FE9C2510
minimum age	18 (xsd:decimal)
medical condition	wds:Q65390948-9FFEF881-4606-411C-AB6B-037D28C8D989
located in the adm...erritorial entity	wds:Q65390948-9DCC6D20-6721-4527-9062-729E8983C39A
sponsor	wds:Q65390948-26E314CF-A384-4A4B-896A-38E7141294AB
medical condition	smallpox
located in the adm...erritorial entity	Puerto Rico
sponsor	Bavarian Nordic
number of participants	wds:Q65390948-D5FD7BC0-4485-472A-8988-DFE829D7073F
number of participants	581 (xsd:decimal)
maximum age	wds:Q65390948-D9215BCB-7226-4651-92D7-416D6A03D5C7
maximum age	55 (xsd:decimal)
study type	wds:Q65390948-F00E0E2F-F411-4A9C-8BA0-09D43761F27F
study type	interventional study
ClinicalTrials.gov ID	wds:Q65390948-4B029F69-6E63-4C8C-8E5F-D2BC26EB1A89
ClinicalTrials.gov ID	NCT00316589
clinical trial phase	wds:Q65390948-CB54F3D4-7527-414D-8A6F-1F9566D8E6C5
clinical trial phase	phase II clinical trial
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q65390948

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 188 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software